Press "Enter" to skip to content

China Initiates Development of mRNA Vaccines

Amnon Free Press/Central Press Syndicate, USA. Read, Enjoy and Share the Latest US News Updates.

While the efficacy of Chinese inactivated vaccines is in doubt, the Pfizer-BioNTech mRNA vaccine is still blocked on the Chinese Communist Party’s (CCP) approval process, and not allowed in mainland China. Meanwhile, state-owned Sinopharm announced it will develop an mRNA vaccine.  On Sept. 6, state-owned First Financial said that the National Pharmaceutical Group Co., Ltd. (Sinopharm) has begun developing an mRNA variant vaccine and expects to launch it next year. Sinopharm is the only central enterprise directly under the State-owned Assets Supervision and Administration Commission that focuses on life and health. Chinese authorities had been resisting mRNA technology in the research for a CCP virus (also called the novel coronavirus) vaccine. “China has chosen a safe and mature inactivated vaccine route, while the mRNA vaccine route is immature and may pose a safety risk,” said mouthpiece Xinhua media on Dec. 29, 2020. However, based on its actual efficacy, “China’s domestically …

To continue reading this news article, follow the link to the news website.

For any inquiries, contact Amnon Free Press (Amnon Jobi Jakony) by writing to editor [at] Discover a world of hyper-local news below.

Other News:   Flight 93 Responders Recall a Time When 9/11 Attack Unified America

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *